Nature's Sunshine Announces Strategic Alliance With Fosun Pharma

Nature's Sunshine enters China, the fastest growing direct selling market in the world, with local strategic partner -- Companies will form a joint venture to market and distribute Nature's Sunshine and Synergy products in China through an innovative multi-channel approach -- Fosun Pharma will acquire approximately 15% stake in Nature's Sunshine, underscoring confidence in its global growth opportunities -- Proceeds of Fosun Pharma investment will fund China market entry and $1.50 per share special one-time cash dividend upon transaction closing

LEHI, Utah, June 26, 2014 -- Nature's Sunshine Products, Inc. (NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196-SH 2196.HK), a leading healthcare company in the People's Republic of China ("China"), announced today the signing of definitive agreements with respect to the formation of a China joint venture to market and distribute Nature's Sunshine and Synergy products in China and an investment by Fosun Pharma of approximately $46.3 million in Nature's Sunshine common stock to be issued pursuant to a private placement transaction.

Read more: Nature's Sunshine Products Inc ( NATR )

An eastern Ontario manufacturer at the forefront of Canada’s budding medical marijuana business is trying to find answers after the RCMP seized a shipment of marijuana it had ordered.

The incident highlights the gray legal area in which medical marijuana manufacturers are opening up shop, under Health Canada’s new rules.

Tweed Inc., which became Canada’s first publicly-traded medical marijuana manufacturer on Friday, says the RCMP seized a shipment of pot at the Kelowna airport that the company had bought from a grower licensed under the previous regime.

[ Read Whole Story ]

Tweed Marijuana Inc. announces closing of qualifying transaction

April 3, 2014 - Tweed Marijuana Inc. (TSXV: LWI.H) ("Tweed Marijuana"), formerly LW Capital Pool Inc., today announced that it has closed its qualifying transaction with Tweed Inc. ("Tweed") pursuant to which Tweed completed a reverse takeover transaction with Tweed Marijuana (the "Transaction") and has delivered all materials to the TSX Venture Exchange (the "Exchange") required to satisfy the listing conditions.  Trading in the common shares of Tweed Marijuana is expected to resume on the Exchange at open of markets on Friday April 4, 2014 under the symbol "TWD".

Prior to the Transaction, Tweed Marijuana was a capital pool company as defined in the policies of the Exchange and had not commenced commercial operations and had no assets other than cash.  The Transaction constituted Tweed Marijuana's "Qualifying Transaction", as defined in Exchange policies.

Tweed is a licensed producer of medical marijuana in Canada.  The principal activities of Tweed are the production and sale of marijuana out of its facility in Smiths Falls, Ontario as regulated by the Marihuana for Medical Purposes Regulations

Read more: Tweed Inc ( TWD )

Neptune and Aker BioMarine Reach Patent Infringement Settlement and License Agreement

Neptune Technologies & Bioressources Inc. ("Neptune") (NEPT) (NTB.TO), Acasti Pharma Inc. ("Acasti") (ACST) (APO.V), a Neptune subsidiary, and Aker BioMarine AS, Aker BioMarine Antarctic AS and Aker BioMarine Antarctic USA (collectively "AKBM") jointly announce a settlement and license agreement that will result in the dismissal of all AKBM respondents from the on-going ITC investigation brought by Neptune and Acasti, as well as the dismissal of all current lawsuits brought by Neptune against AKBM and companies in its value chain.

Read more: Neptune Technologies & Bioressources ( NEPT )

Neptune Reports Fiscal 2012 Results

Nutraceutical Net Income Increases by More Than 100%

Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT - News) (TSX:NTB.TO - News) reports today its consolidated financial results for the fiscal year ended February 29, 2012, announces corporate reorganization and the holding of an earning call.

Fiscal year ended February 29, 2012 Financial Results

Nutraceutical Business Results
    Nutraceutical revenues increased by 15% to a record $19,113,000, for the fiscal year ended February 29, 2012, up from $16,583,000 achieved during the corresponding period ended February 28, 2011.

Read more: Neptune Technologies & Bioressources Inc ( NTB )

Videos / Webinars

View all videos